Differentiating among nonsteroidal antiinflammatory drugsby pharmacokinetic and pharmacodynamic profiles
- 1 June 1997
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 26, 28-33
- https://doi.org/10.1016/s0049-0172(97)80050-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysisBMJ, 1996
- Selective inhibition of human cyclo-oxygenase-2 by meloxicamInflammopharmacology, 1996
- Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and-2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 productionInflammation Research, 1996
- Safety of Meloxicam: A Global Analysis of Clinical TrialsRheumatology, 1996
- A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitorsInflammation Research, 1996
- Meloxican: Influence on arachidonic acid metabolism: Part 1. In vitro findingsBiochemical Pharmacology, 1996
- Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (LODINE)Inflammopharmacology, 1995
- Effects of nabumetone on prostanoid biosynthesis in humans*Clinical Pharmacology & Therapeutics, 1995
- Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.Journal of Biological Chemistry, 1993